Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon-like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as Treatment of Idiopathic Intracranial Hypertension

NCT06027567 is registered in ClinicalTrials.gov with Rigmor Højland Jensen as lead sponsor.

NCT NCT06027567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon-like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as Treatment of Idiopathic Intracranial Hypertension
Lead sponsor
Rigmor Højland Jensen
Phase
Phase 4
Overall status
Completed
Start date
September 2, 2022
Completion date
October 28, 2025
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic intracranial hypertension, intracranial pressure, obesity, papilledema, pseudotumor cerebri syndrome, weight loss